Acacia Designs is a clinical innovation company founded by industry leaders in the field of anesthesia. The mission is to develop solutions that reduce the prevalence of post-operative complications resulting from the use of paralytic drugs (NMBAs).
Every year more than 20 million patients are affected by post-operative complications related to NMBAs and inadequate perioperative neuromuscular monitoring.
The Acacia team has developed novel, patent pending solutions for monitoring patients undergoing anesthesia to determine when it is safe to wake up the patient and allow spontaneous breathing following surgery.
Developing the New Global Standards of Perioperative Safety.
Latest company news:
May 02, 2016
Senzime is a Swedish publicly traded medical device company developing novel solutions for postoperative monitoring. Acacia and Senzime have entered into an agreement whereby the companies merge as Senzime technically acquires Acacia. The closing is followed by a fully guaranteed rights issue. The merger of Senzime’s and Acacia’s businesses creates a company with a broad and unique offering of systems and products for continuous monitoring of biological and physiological processes in patients during and after surgery. Read more here
In the February 2016 offical journal of the APSF, neuromuscular blockade is highligheted with a number of articles. The Editors conclude that “…all anesthesia professionals should understand the importance of appropriately monitoring and reversing neuromuscular blockade. We believe that these articles will increase awareness, provide important educational information and improve patient safety.”
The clinical
problem
Acacia's
solutions
The Acacia
team
Every day, more than 500,000 patients are put to sleep with general anesthesia to enable surgery.
Every single patient
deserves a bright recovery.
The clinical
problem
Acacia's
solutions
The Acacia
team
And every day, more than 50,000 patients patients are affected by post-operative complications related to anesthesia and inadequate perioperative monitoring.
Acacia has developed the solution
The clinical
problem
Acacia's
solutions
The Acacia
team
Acacia has developed the solution.
Only 1 in 4 patients are adequately monitored to determine when it is safe to wake up the patient and allow spontaneous breathing following surgery.
The clinical
problem
Acacia's
solutions
The Acacia
team
Acacia has developed the solution.
Postoperative respiratory complications lead to a 12-fold increase in surgical costs, and a significant burden on patients.
The clinical
problem
Acacia's
solutions
The Acacia
team
It's about time someone develops the new global standards of perioperative safety.